Analytic Investors’s Bio-Techne TECH Stock Holding History

Analytic Investors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$466K	Sell	17,044 -22,452	-57%	-$617K	0.01%	486
2016 Q2	$1.11M	Buy	39,496 +344	+0.9%	+$8.84K	0.01%	363
2016 Q1	$925K	Buy	+39,152	New	+$862K	0.01%	409
2014 Q2	–	Sell	-273,344	Closed	-$5.83M	–	599
2014 Q1	$5.83M	Sell	273,344 -352,220	-56%	-$7.93M	0.09%	177
2013 Q4	$14.8M	Buy	625,564 +2,200	+0.4%	+$47.7K	0.25%	111
2013 Q3	$12.5M	Buy	623,364 +7,272	+1%	+$138K	0.2%	128
2013 Q2	$10.6M	Buy	+616,092	New	+$10.2M	0.18%	149

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Analytic Investors's TECH Position: Q3 2016 in Review

Analytic Investors reduced its Bio-Techne (TECH) stake by 57% in Q3 2016, selling an estimated $617K and leaving 17,044 shares worth $466K. The position accounts for 0.01% of the portfolio, ranked #486.

Analytic Investors first reported a position in TECH in Q2 2013 and has held it in 7 quarters since. The position peaked at $14.8M in Q4 2013. 293 funds tracked by Wall St. Rank hold TECH as of Q3 2016.

Analytic Investors held 17,044 shares of Bio-Techne worth $466K as of Q3 2016.
Analytic Investors sold 22,452 Bio-Techne shares in Q3 2016, an estimated $617K.
Bio-Techne made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #486 holding.
Analytic Investors first reported a position in Bio-Techne in Q2 2013 and has held it in 7 quarters since.
Analytic Investors's Bio-Techne position peaked at $14.8M in Q4 2013.
293 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.